Chen Xinglong, Yan Jin, Huang Dingqiang
Department of Otolaryngology-Head and Neck Surgery, Chengdu Second People's Hospital, Chengdu Second Clinical Teaching Training Center Affiliated to Chongqing Medical University, Chengdu Institute of Dermatology and STD Prevention, Chengdu, China.
Department of Emergency Medicine, Chengdu Seventh People's Hospital, Chengdu, China.
Transl Cancer Res. 2022 Dec;11(12):4381-4388. doi: 10.21037/tcr-22-2539.
Whether increased antibiotic duration is necessary for surgical site infection (SSI) in patients after neck surgery is unclear. We investigated the characteristics of SSI, and the impact of SSI on increased antibiotic duration among patients with laryngocarcinoma (LC).
A retrospective cohort study including consecutive LC patients ≥18 years, undergoing surgery without remote metastasis was conducted from October 2015 to February 2022 in the Department of Otolaryngology-Head and Neck Surgery, Chengdu Second People's Hospital. SSI was defined according to current guidelines. Patients were stratified into 3 groups including no-infection, lower respiratory tract infection (LRTI) and SSI. Patient characteristics was recorded. Patients were followed up until discharge. A multiple linear regression model including SSI and other factors including age, sex, comorbidity and antibiotic treatments was performed to explore the impact of SSI on increased antibiotic duration among LC patients with postoperative infection.
A total of 88 patients were included, with 26 (29.5%) in no-infection group, 38 (43.2%) in LRTI group, and 24 (27.3%) in SSI group. Laryngocutaneous fistula occurred in 8 (33.3%) patients with SSI. Thirteen (34.2%) patients in LRTI group and 9 (37.5%) patients in SSI group experienced postoperative infection within 2 days after surgery, and antibiotic susceptibility tests were performed in 18 (47.4%) and 12 (50.0%) patients in LRTI and SSI group, respectively (P>0.05 for both). Levofloxacin and cefoperazone-sulbactam were the most commonly used antibiotics for postoperative infection in both LRTI and SSI groups (P>0.05 for both), irrespective of antibiotic susceptibility tests or not. The postoperative antibiotic duration in SSI group was significantly longer than that in LRTI group (13.62±4.28 days in SSI 11.22±3.64 days in LRTI, P=0.021). A multiple linear regression analysis including SSI, age, sex, diabetes, antibiotic susceptibility test and hypoalbuminemia showed that, SSI was independently associated with increased antibiotic duration with LRTI as the reference among LC patients diagnosed [regression coefficient β=3.02, 95% confidence interval (CI): 1.01-5.03, P=0.004], whereas antibiotic susceptibility test was not (P=0.467).
SSI may be independently associated with increased postoperative antibiotic duration in patients with LC with or without antibiotic susceptibility test.
颈部手术后患者手术部位感染(SSI)是否需要延长抗生素使用时间尚不清楚。我们调查了喉癌(LC)患者SSI的特征,以及SSI对延长抗生素使用时间的影响。
2015年10月至2022年2月,在成都市第二人民医院耳鼻咽喉头颈外科进行了一项回顾性队列研究,纳入年龄≥18岁、接受手术且无远处转移的连续LC患者。根据现行指南定义SSI。患者分为3组,包括无感染组、下呼吸道感染(LRTI)组和SSI组。记录患者特征。对患者进行随访直至出院。采用多元线性回归模型,纳入SSI以及年龄、性别、合并症和抗生素治疗等其他因素,以探讨SSI对LC术后感染患者抗生素使用时间延长的影响。
共纳入88例患者,无感染组26例(29.5%),LRTI组38例(43.2%),SSI组24例(27.3%)。8例(33.3%)SSI患者发生了喉皮肤瘘。LRTI组13例(34.2%)患者和SSI组9例(37.5%)患者在术后2天内发生术后感染,LRTI组和SSI组分别有18例(47.4%)和12例(50.0%)患者进行了抗生素敏感性试验(两者P>0.05)。左氧氟沙星和头孢哌酮-舒巴坦是LRTI组和SSI组术后感染最常用的抗生素(两者P>0.05),无论是否进行抗生素敏感性试验。SSI组术后抗生素使用时间显著长于LRTI组(SSI组为13.62±4.28天,LRTI组为11.22±3.64天,P=0.021)。一项纳入SSI、年龄、性别、糖尿病、抗生素敏感性试验和低蛋白血症的多元线性回归分析显示,在确诊的LC患者中,以LRTI为参照,SSI与抗生素使用时间延长独立相关[回归系数β=3.02,95%置信区间(CI):1.01-5.03,P=0.004],而抗生素敏感性试验则不然(P=0.467)。
在有或没有抗生素敏感性试验的LC患者中,SSI可能与术后抗生素使用时间延长独立相关。